Pilot Study to Assess the Quantitative Dermal Transfer Efficiencies of Solids for Multiple Transfer Pathways

NCT ID: NCT02529748

Last Updated: 2019-08-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

10 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-08-01

Study Completion Date

2019-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Dermal transfer efficiency has been defined as the amount of material that moves from one surface to another following contact. The investigators propose to measure dermal transfer efficiency for the following pathways: (1) object to skin, (2) skin to skin, (3) skin to mouth, (4) clothing to skin, (5) gloves to skin, and (6) air to skin. First, the quantitative dermal transfer will be measured for the two selected test substances (lead, Tinopal) for each of these six pathways. The relative quantities of dermal transfer will also then be compared between the different transfer pathways (e.g., is skin to skin transfer greater or less than clothing to skin transfer?). And second, the pattern of transfer will be characterized semi-quantitatively (e.g., does dermal transfer occur consistently and evenly to the skin from different reservoirs?).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Each of the six transfer pathways will be tested and measured in a controlled, ventilated study chamber at the University of Minnesota's School of Public Health Industrial Hygiene Laboratory. To test each pathway, human volunteers will perform repeated contact activities using an identical protocol (e.g., identical number of contacts, type of material contacted, measured pressure of contact, measured time of contact, measured temperature and humidity) so that inter- and intra-individual variability can be characterized.

The qualitative and quantitative sampling methods that will be used have been developed, tested, and published by researchers from the National Institute for Occupational Safety and Health (NIOSH) and other institutions such as ASTM. Specifically, quantitative transfer efficiencies will be measured using accepted wipe sampling protocols taken from several papers in the peer-reviewed literature. Semi-quantitative transfer patterns will be measured using fluorescent tracer intensity techniques that have also been presented in the peer-reviewed literature. The skin surface wipe samples will be sent to an accredited American Industrial Hygiene Association (AIHA) laboratory for analysis.

These sampling results will allow the investigators to report the measured quantitative dermal transfer efficiencies of elemental metallic lead and Tinopal for each pathway in mass per square surface area of skin, and also calculate the relative transfer efficiencies in terms of percent transferred versus originally loaded. Fluorescent tracer maps will allow the investigators to demonstrate the patterns of transfer for each pathway using intensity of the tracer following transfer. Following this analysis, the investigators will then use the data to better inform the relative importance of the pathways in the conceptual model with respect to dermal exposure assessment and modeling efforts. These results are very important for improving the quality of workplace dermal exposure assessments and techniques. The current approaches are not well validated, and it is unknown if the results of existing dermal exposure models are accurate. It is expected that the results of this study will help to improve the protection of workers from certain dermal exposure hazards in the workplace by providing better inputs to the existing dermal exposure models, since it is not possible to collect exposure samples for each job task in the workplace.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Environmental Exposure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Participants for Surface Skin Sampling

Adult volunteers with healthy, intact skin will have surface skin wipe samples collected following contact with the approved test substances to measure the quantitative transfer of the test substances to and from the skin surface.

Group Type EXPERIMENTAL

Participants for Surface Skin Sampling

Intervention Type OTHER

Skin wipe samples will be collected to quantify the amount of the test substances transferred to and from the surface of the participants' skin.

Elemental metallic lead

Intervention Type OTHER

Consumer product fishing tackle made of elemental lead will be handled by the participants.

Tinopal

Intervention Type OTHER

Tinopal, a fluorescent tracer, will be handled by the participants.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Participants for Surface Skin Sampling

Skin wipe samples will be collected to quantify the amount of the test substances transferred to and from the surface of the participants' skin.

Intervention Type OTHER

Elemental metallic lead

Consumer product fishing tackle made of elemental lead will be handled by the participants.

Intervention Type OTHER

Tinopal

Tinopal, a fluorescent tracer, will be handled by the participants.

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

No other names No other names No other names

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult volunteers with healthy intact skin.

Exclusion Criteria

* Children will be excluded from the study.
* Adults with a past history of dermal sensitization, skin allergy, or dermal irritation or dermatitis because of the potential to have compromised barrier function in the skin.
* Adults who are unwilling to follow protocol requirements.
* Adults who have a documented history of lead poisoning.
* Adults who have a concurrent contagious illness or other stressor which in the opinion of the investigator may interfere with the subject's ability to perform the study's requirements.
* Adults who have open wounds or otherwise compromised skin integrity on their hands.
* Adults who are pregnant or nursing.
* Adults who lack the capacity to provide informed voluntary consent to participate in the study.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Minnesota

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Minnesota

Minneapolis, Minnesota, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1506M73781

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.